Structure |
Chemical Name |
CAS |
MF |
|
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
|
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline |
190728-25-7 |
C17H16N2O3 |
|
Indoline |
496-15-1 |
C8H9N |
|
3-CYANOCOUMARIN |
15119-34-3 |
C10H5NO2 |
|
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
2186604-89-5 |
C42H80O3Si3 |
|
Anti-Cyclooxygenase 3/Cox3 |
|
|
|
Ceftazidime and Avibactam Sodium for Injection |
|
|
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 |
59894-07-4 |
C20H32O5 |
|
9-OXO-11ALPHA-15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
34210-10-1 |
C20H28D4O5 |
|
5-(4-Hydroxyphenyl)-2,4-imidazolidinedione |
2420-17-9 |
C9H8N2O3 |
|
2-Azepan-1-yl-ethylamine |
51388-00-2 |
C8H18N2 |
|
4,7-DIHYDROXYCOUMARIN |
1983-81-9 |
C9H6O4 |
|
(9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate |
|
|
|
(9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate |
|
|
|
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
118864-75-8 |
C15H15N |
|
(2S,3R)-2-amino-3-methylpent-4-enamide |
2209873-96-9 |
C6H12N2O |
|
4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol |
20051-76-7 |
C20H27NO3 |
|
Carbamazepine intermediate |
|
|
|
1-[2-(Dimethylamino)ethyl]-1H-tetrazole-5-thiol |
61607-68-9 |
C5H11N5S |
|
(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL |
913742-54-8 |
C11H21ClN2O4 |
|
Indacaterol interMediate |
435273-75-9 |
C31H34N2O3 |
|
5-Hydroxy-3,4-dihydroquinolin-2(1H)-one |
30389-33-4 |
C9H9NO2 |
|
[2S-[2α(R*),3β]]-N-ForMyl- |
104872-28-8 |
C29H53NO5 |
|
7-DesMethylagoMelatine |
152302-45-9 |
C14H15NO2 |
|
2-Propenoic acid, 3-(5-nitro-1-cyclohexen-1-yl)-, (2E)- |
899809-64-4 |
C9H11NO4 |
|
Aegelin |
456-12-2 |
C18H19NO3 |
|
1,2,4-cyclohexanetricarboxylic anhydride |
53611-01-1 |
C9H10O5 |
|
3,4-Diethyl 2-aMinothiophene-3,4-dicarboxylate |
104680-25-3 |
C10H13NO4S |
|
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
|
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
|
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
|
LOXO-292 |
2222755-14-6 |
C29H31N9O3 |
|
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
|
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
|
Prednisone Impurity 13 |
91160-89-3 |
C23H29BrO7 |
|
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
|
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
|
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
|
(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate |
1428484-17-6 |
C36H51F5O4S |
|
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
|
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
|
2’-deoxyinosine |
|
|
|
Anti-Ceftriaxong |
|
|
|
benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240582-25-5 |
C11H19F3N2O2 |
|
4-hydroxy-6H-coumarin |
213481-01-7 |
C15H15NO3 |
|
1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
951259-19-1 |
C11H16IN3O2 |
|
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
|
2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE |
3528-45-8 |
C11H13N3O |
|
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |
|
5-Mercapto-1H-tetrazole-1-methane sulphonic acid |
67146-22-9 |
C2H4N4O3S2 |
|
(R)-ethyl thiazolidine-4-carboxylate |
|
C6H11NO2S |
|
(6R,7S)-Ceftriaxone Epimer |
|
|
|
tert-butyl 4-(3-(methoxycarbonyl)phenyl)piperidine-1-carboxylate |
1016980-41-8 |
C18H25NO4 |
|
[3,3']Biazetidinyl-1-carboxylicacidtert-butylester |
1251018-87-7 |
C11H20N2O2 |
|
4-(Bromomethyl)-7-(diethylamino)coumarin |
1256259-14-9 |
C14H16BrNO2 |
|
TERT-BUTYL 3-((2-ETHOXY-2-OXOETHYL)SULFONYL)AZETIDINE-1-CARBOXYLATE |
1648864-57-6 |
C12H21NO6S |
|
2-Oxo-1-benzimidazolinebutyric Acid |
3273-68-5 |
C11H12N2O3 |
|
methyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyrimidine-5-carboxylate |
1057682-17-3 |
C15H22N4O4 |
|
tert-butyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
△3-Cefuroxime |
|
|
|
Flomoxef Intermediate KDFA |
|
|
|
Polymethylhydrosiloxane |
9004-73-3 |
C5H11OSi* |
|
3H-3-Azadibenzo[g,ij]naphth[2,1,8-cde]azulene |
2408302-78-1 |
C22H13N |
|
tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(3S,4S,5S)-Oseltamivir |
|
|
|
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
|
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- |
2198312-46-6 |
C12H18BrN3O2 |
|
3-(3'-TRIFLUOROMETHYL PHENYL) PROPANOL |
78573-45-2 |
C10H11F3O |
|
((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol hydrochloride |
2416218-32-9 |
C8H14FNO.ClH |
|
3-acetyl-4-hydroxy-2-benzopyrone |
2555-37-5 |
C11H8O4 |
|
5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847464-89-4 |
C29H35N7O5 |
|
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- |
2145122-45-6 |
C10H17NO5S |
|
4-MAR |
|
|
|
Δ3-Ceftiofur |
|
|
|
N-(4-CYANO-PHENYL)-GLYCINE |
42288-26-6 |
C9H8N2O2 |
|
DeoxyBenzoinOxime |
952-06-7 |
C14H13NO |
|
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
|
20-hydroxy Prostaglandin F2a |
|
|
|
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
|
3-Acetylbiphenyl |
3112-01-4 |
C14H12O |
|
(S)-3-Cyano-5-methylhexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
|
Trityl candesartan cilexetil |
170791-09-0 |
C52H48N6O6 |
|
Chloropretadalafil |
171489-59-1 |
C22H19ClN2O5 |
|
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
|
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
|
3-FLUOROINDOLE |
66946-81-4 |
C8H6FN |
|
Cefetecol |
117211-03-7 |
C20H17N5O9S2 |
|
Ranolazine-d3 |
1054624-77-9 |
C24H33N3O4 |
|
5-BENZYLIDENEHYDANTOIN |
3775-01-7 |
C10H8N2O2 |
|
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
|
Clopidogrel camphorsulfonate |
120202-68-8 |
C26H32ClNO6S2 |
|
(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity) |
130793-28-1 |
C29H55NO6 |
|
N4-Acetyl-2'-O-Methyl-cytidine |
113886-71-8 |
C12H17N3O6 |
|
5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine |
1010120-55-4 |
C6H5BrN4 |
|
4,4'-Dibromo-2,2'-diiodobiphenyl |
852138-89-7 |
C12H6Br2I2 |
|
Sterolazole intermediate |
|
|
|
2',3'-Anhydroinosine |
31766-13-9 |
C10H10N4O4 |